JAC Advance Access published online on June 3, 2006
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkl239
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Infectious Diseases Service, Hospital São Lucas da Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil; Medicine: Medical Sciences Postgraduate Program, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
* To whom correspondence should be addressed. Objectives: To assess the effect of metallo- Methods: A cohort study of patients with P. aeruginosa nosocomial infections was conducted at two teaching hospitals. MBL was detected by ceftazidime/2-mercaptopropionic disc approximation test and selected isolates were submitted to PCR using blaSPM-1 primer. Molecular typing was performed by DNA macrorestriction. To evaluate the influence of MBL on mortality a Cox proportional hazards model was performed using a hierarchized framework of the variables. Results: A total of 298 patients with P. aeruginosa infections were included. Infections by MBL-carrying Pseudomonas aeruginosa (MBL-PA) resulted in higher in-hospital mortality than those by non-MBL-PA (51.2% versus 32.1%, respectively; relative risk 1.60, 95% CI 1.20-2.12) and higher mortality rates [17.3 per 1000 versus 11.8 per 1000 patient-days, respectively; hazard ratio (HR) 1.55, 95% CI 1.06-2.27]. In the final multivariate model, severe sepsis or septic shock [adjusted HR (AHR) 3.62, 95% CI 2.41-5.43], age (AHR 1.02, 95% CI 1.01-1.03) and use of appropriate therapy Conclusions: MBL-PA infections resulted in higher mortality rates most likely related to the severity of these infections and less frequent early institution of appropriate antimicrobial therapy. Empirical treatments should be reviewed at institutions with high prevalence of MBL.
Received February 8, 2006
Accepted May 12, 2006
Original article
The influence of metallo-
Alexandre Prehn Zavascki 1 *,
Afonso Luís Barth 2,
Ana Lúcia Saraiva Gonçalves 3,
Ana Lúcia Didonet Moro 4,
Juliana Fernandez Fernandes 5,
Andreza Francisco Martins 3,
Fabiano Ramos 6,
and
Luciano Zubaran Goldani 7
-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections
2 Medicine: Medical Sciences Postgraduate Program, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; Microbiology Unit, Clinical Pathology Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
3 Microbiology Unit, Clinical Pathology Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
4 Medical School, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil
5 Medical School, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
6 Infectious Diseases Service, Hospital São Lucas da Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil
7 Medicine: Medical Sciences Postgraduate Program, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; Division of Infectious Diseases, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
Alexandre Prehn Zavascki, E-mail: apzavascki{at}terra.com.br
![]()
Abstract
-lactamase (MBL) production on Pseudomonas aeruginosa nosocomial infection mortality and to identify the determinants of such effect.
72 h (AHR 0.49, 95% CI 0.32-0.76) were significantly associated with mortality. Fourteen MBL-PA tested carried the blaSPM-1 gene. Clonal dissemination was documented in both hospitals.
-lactamases; nosocomial infections.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. al Naiemi, M. C. Rijnsburger, P. H. M. Savelkoul, C. M. J. Vandenbroucke-Grauls, and Y. J. Debets-Ossenkopp Emergence of metallo-{beta}-lactamases in the Netherlands J. Med. Microbiol., October 1, 2009; 58(10): 1398 - 1399. [Full Text] [PDF] |
||||
![]() |
A. A. El Solh and A. Alhajhusain Update on the treatment of Pseudomonas aeruginosa pneumonia J. Antimicrob. Chemother., August 1, 2009; 64(2): 229 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pellegrini, P. S. Mercuri, G. Celenza, M. Galleni, B. Segatore, E. Sacchetti, R. Volpe, G. Amicosante, and M. Perilli Identification of blaIMP-22 in Pseudomonas spp. in urban wastewater and nosocomial environments: biochemical characterization of a new IMP metallo-enzyme variant and its genetic location J. Antimicrob. Chemother., May 1, 2009; 63(5): 901 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-t. Qu, J.-l. Zhang, J. Wang, J. Tao, Y.-s. Yu, Y.-g. Chen, J.-y. Zhou, and L.-j. Li Evaluation of Phenotypic Tests for Detection of Metallo-{beta}-Lactamase-Producing Pseudomonas aeruginosa Strains in China J. Clin. Microbiol., April 1, 2009; 47(4): 1136 - 1142. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Picao, S. S. Andrade, A. G. Nicoletti, E. H. Campana, G. C. Moraes, R. E. Mendes, and A. C. Gales Metallo-{beta}-Lactamase Detection: Comparative Evaluation of Double-Disk Synergy versus Combined Disk Tests for IMP-, GIM-, SIM-, SPM-, or VIM-Producing Isolates J. Clin. Microbiol., June 1, 2008; 46(6): 2028 - 2037. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Zavascki, A. L. Barth, and L. Z. Goldani Nosocomial bloodstream infections due to metallo-{beta}-lactamase-producing Pseudomonas aeruginosa J. Antimicrob. Chemother., May 1, 2008; 61(5): 1183 - 1185. [Full Text] [PDF] |
||||
![]() |
C. G. Giske, D. L. Monnet, O. Cars, Y. Carmeli, and on behalf of ReAct-Action on Antibiotic Resistance Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli Antimicrob. Agents Chemother., March 1, 2008; 52(3): 813 - 821. [Full Text] [PDF] |
||||
![]() |
A. P. Zavascki, L. Z. Goldani, J. Li, and R. L. Nation Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review J. Antimicrob. Chemother., December 1, 2007; 60(6): 1206 - 1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Zavascki, A. L. Barth, P. B. Gaspareto, A. L. S. Goncalves, A. L. D. Moro, J. F. Fernandes, and L. Z. Goldani Risk factors for nosocomial infections due to Pseudomonas aeruginosa producing metallo-{beta}-lactamase in two tertiary-care teaching hospitals J. Antimicrob. Chemother., October 1, 2006; 58(4): 882 - 885. [Abstract] [Full Text] [PDF] |
||||



